by Lucy Prior | Nov 30, 2023 | Press Releases, Welcome
Isogenica announces two Pioneering Collaborations with an Antibody Research and License Agreement, and an Asset Evaluation Deal Isogenica, a leading innovator in VHH antibodies, is proud to unveil two significant collaborations using its synthetic VHH technology,...
by Lucy Prior | Sep 7, 2023 | Bi-specific resources, VHHs
The golden age of bi-specific antibodies is here Bi-specific antibodies (BsAbs) – antibodies that can recognise two different epitopes on either the same or different antigens – have been around for a long time. However, in the past few years we’ve seen a...